News from the FDA/CDC
News
Nearly 10% of hospitalized patients with COVID-19 later readmitted
News from the FDA/CDC
CDC panel takes on COVID vaccine rollout, risks, and side effects
ACIP will need to offer direction on which groups should get priority in vaccine allocation, inasmuch as early supplies will not be sufficient to...
News from the FDA/CDC
Teen vaping in the time of COVID-19
occurred...
News
FDA posts COVID vaccine guidance amid White House pushback
In the new guidance document, FDA officials outline what will be required for even a limited clearance, known as an emergency use authorization,...
News from the FDA/CDC
FDA expands remdesivir use for all COVID-19 hospitalized patients
An EUA of remdesivir issued in May allowed the drug to be used only for patients with severe COVID-19, specifically, COVID-19 patients with low...
News from the FDA/CDC
FDA approves point-of-care COVID-19 antigen test
“This new COVID-19 antigen test is an important addition to available tests because the results can be read in minutes, right off the testing card...
News from the FDA/CDC
FDA approves clinical trials for cannabinoid drug designed to reduce COVID-19 lung inflammation
The drug going to clinical trials, ARDS-003, would “dampen the cytokine release” and prevent development of ARDS.
News
FDA updates hydrochlorothiazide label to include nonmelanoma skin cancer risk
Patients should continue taking the antihypertensive drug unless their doctor says otherwise, according to an FDA...
News from the FDA/CDC
COVID-19: Medicare data show long hospital stays, disparities
Many beneficiaries “face structural challenges to their health,” said CMS Administrator Seema Verma.
News from the FDA/CDC
ED visits for life-threatening conditions declined early in COVID-19 pandemic
Visits for MI, stroke, and hypoglycemic crisis dropped 10%-23% over the first 10 weeks.
News from the FDA/CDC
U.S. adults reach Healthy People 2020 cholesterol goal